24/7 Clients Support
- 24/7
Customer Service
- ISO 9001
Certification Company
- WHO-GMP
Certified Company
ACALIEVA 100MG is an Capsule medication used for treatment purposes. It is manufactured by Allieva Pharma Private Limited.
| Brand Name | ACALIEVA 100MG |
|---|---|
| Composition | Acalabrutinib Capsules 100mg |
| Manufacturer | Allieva Pharma Private Limited |
| Dosage Form | Capsule |
| Packaging | Btl (30 cap) |
| Country of Origin | India |
Acalabrutinib Capsules 100mg (Acalabrutinib Capsules 100mg) is a widely used Capsule medicine manufactured by Allieva Pharma Private Limited. It is commonly prescribed for...
ACALIEVA contains Acalabrutinib, a second-generation Bruton’s Tyrosine Kinase (BTK) inhibitor. It works by blocking BTK signaling in B-cells, thereby inhibiting the growth and survival of malignant B-lymphocytes.
Acalabrutinib is indicated for the treatment of:
1. Chronic Lymphocytic Leukemia (CLL)
2. Small Lymphocytic Lymphoma (SLL)
3. Mantle Cell Lymphoma (MCL) – in patients who have received at least one prior therapy
Common side effects:
• Headache
• Diarrhea
• Fatigue
• Muscle pain
• Upper respiratory tract infections
Hematological:
• Anemia
• Neutropenia
• Thrombocytopenia
Serious side effects:
• Bleeding events
• Atrial fibrillation
• Severe infections
• Standard dose: 100 mg orally twice daily
• Swallow capsules whole with water
• Can be taken with or without food
• Avoid proton pump inhibitors; separate dosing from antacids or H2 blockers
NOTE: This medicine should be taken only under a doctor’s supervision.